Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 111 entries
Sorted by: Best Match Show Resources per page
Cancer-cell seeding of operative wounds.

Journal of the National Cancer Institute

SMITH RR, HILBERG AW.
PMID: 13272023
J Natl Cancer Inst. 1955 Dec;16(3):645-57.

No abstract available.

Cite
SMITH RR, HILBERG AW. Cancer-cell seeding of operative wounds. J Natl Cancer Inst. 1955;16(3):645-57
SMITH, R. R., & HILBERG, A. W. (1955). Cancer-cell seeding of operative wounds. Journal of the National Cancer Institute, 16(3), 645-57.
SMITH, R R, and HILBERG, A W. "Cancer-cell seeding of operative wounds." Journal of the National Cancer Institute vol. 16,3 (1955): 645-57.
SMITH RR, HILBERG AW. Cancer-cell seeding of operative wounds. J Natl Cancer Inst. 1955 Dec;16(3):645-57. PMID: 13272023.
Copy Download .nbib Format: NLM
[A new method for the demonstration of physiological and pathological processes in nature and human beings in relation to carcinogenesis].

Hippokrates

CURRY M, RUHLICKE K.
PMID: 12989797
Hippokrates. 1952 Apr 15;23(7):182-5.

No abstract available.

Cite
CURRY M, RUHLICKE K. Eine neuartige Methode zur Darstellung physiologischer und pathologischer Vorgänge in der Natur und im menschlichen Organismus unter Berücksichtigung eines krebsaktivierenden Faktors. [A new method for the demonstration of physiological and pathological processes in nature and human beings in relation to carcinogenesis]. Hippokrates. 1952;23(7):182-5
CURRY, M., & RUHLICKE, K. (1952). Eine neuartige Methode zur Darstellung physiologischer und pathologischer Vorgänge in der Natur und im menschlichen Organismus unter Berücksichtigung eines krebsaktivierenden Faktors. [A new method for the demonstration of physiological and pathological processes in nature and human beings in relation to carcinogenesis]. Hippokrates, 23(7), 182-5.
CURRY, M, and RUHLICKE, K. "Eine neuartige Methode zur Darstellung physiologischer und pathologischer Vorgänge in der Natur und im menschlichen Organismus unter Berücksichtigung eines krebsaktivierenden Faktors." [A new method for the demonstration of physiological and pathological processes in nature and human beings in relation to carcinogenesis]. Hippokrates vol. 23,7 (1952): 182-5.
CURRY M, RUHLICKE K. Eine neuartige Methode zur Darstellung physiologischer und pathologischer Vorgänge in der Natur und im menschlichen Organismus unter Berücksichtigung eines krebsaktivierenden Faktors. [A new method for the demonstration of physiological and pathological processes in nature and human beings in relation to carcinogenesis]. Hippokrates. 1952 Apr 15;23(7):182-5. Undetermined. PMID: 12989797.
Copy Download .nbib Format: NLM
A biological principle and its converse: some implications for carcinogenesis.

Nature

BURCH PR.
PMID: 13874718
Nature. 1962 Jul 21;195:241-3. doi: 10.1038/195241a0.

No abstract available.

Cite
BURCH PR. A biological principle and its converse: some implications for carcinogenesis. Nature. 1962;195:241-3doi: 10.1038/195241a0.
BURCH, P. R. (1962). A biological principle and its converse: some implications for carcinogenesis. Nature, 195241-3. https://doi.org/10.1038/195241a0
BURCH, P R. "A biological principle and its converse: some implications for carcinogenesis." Nature vol. 195 (1962): 241-3. doi: https://doi.org/10.1038/195241a0
BURCH PR. A biological principle and its converse: some implications for carcinogenesis. Nature. 1962 Jul 21;195:241-3. doi: 10.1038/195241a0. PMID: 13874718.
Copy Download .nbib Format: NLM
Systemic factors in carcinogenesis.

Canadian Medical Association journal

SKORYNA SC.
PMID: 13652006
Can Med Assoc J. 1959 May 01;80(9):689-97.

No abstract available.

Cite
SKORYNA SC. Systemic factors in carcinogenesis. Can Med Assoc J. 1959;80(9):689-97
SKORYNA, S. C. (1959). Systemic factors in carcinogenesis. Canadian Medical Association journal, 80(9), 689-97.
SKORYNA, S C. "Systemic factors in carcinogenesis." Canadian Medical Association journal vol. 80,9 (1959): 689-97.
SKORYNA SC. Systemic factors in carcinogenesis. Can Med Assoc J. 1959 May 01;80(9):689-97. PMID: 13652006; PMCID: PMC1830840.
Copy Download .nbib Format: NLM
A new theory on cancer-inducing mechanism.

British journal of cancer

NORDLING CO.
PMID: 13051507
Br J Cancer. 1953 Mar;7(1):68-72. doi: 10.1038/bjc.1953.8.

No abstract available.

Cite
NORDLING CO. A new theory on cancer-inducing mechanism. Br J Cancer. 1953;7(1):68-72doi: 10.1038/bjc.1953.8.
NORDLING, C. O. (1953). A new theory on cancer-inducing mechanism. British journal of cancer, 7(1), 68-72. https://doi.org/10.1038/bjc.1953.8
NORDLING, C O. "A new theory on cancer-inducing mechanism." British journal of cancer vol. 7,1 (1953): 68-72. doi: https://doi.org/10.1038/bjc.1953.8
NORDLING CO. A new theory on cancer-inducing mechanism. Br J Cancer. 1953 Mar;7(1):68-72. doi: 10.1038/bjc.1953.8. PMID: 13051507; PMCID: PMC2007872.
Copy Download .nbib Format: NLM
Genetic evolution during tumor progression: from basic research to clinical practice.

Cancer metastasis reviews

Tímár J.
PMID: 26961284
Cancer Metastasis Rev. 2016 Mar;35(1):3-4. doi: 10.1007/s10555-016-9603-7.

No abstract available.

Cite
Tímár J. Genetic evolution during tumor progression: from basic research to clinical practice. Cancer Metastasis Rev. 2016;35(1):3-4doi: 10.1007/s10555-016-9603-7.
Tímár, J. (2016). Genetic evolution during tumor progression: from basic research to clinical practice. Cancer metastasis reviews, 35(1), 3-4. https://doi.org/10.1007/s10555-016-9603-7
Tímár, József. "Genetic evolution during tumor progression: from basic research to clinical practice." Cancer metastasis reviews vol. 35,1 (2016): 3-4. doi: https://doi.org/10.1007/s10555-016-9603-7
Tímár J. Genetic evolution during tumor progression: from basic research to clinical practice. Cancer Metastasis Rev. 2016 Mar;35(1):3-4. doi: 10.1007/s10555-016-9603-7. PMID: 26961284.
Copy Download .nbib Format: NLM
Gut Microbiota as a Positive Potential Therapeutic Factor in Carcinogenesis: an Overview of Microbiota-Targeted Therapy.

Journal of gastrointestinal cancer

Joukar F, Mavaddati S, Mansour-Ghanaei F, Samadani AA.
PMID: 31025167
J Gastrointest Cancer. 2020 Jun;51(2):363-378. doi: 10.1007/s12029-019-00237-6.

Cancer therapeutic methods comprising chemotherapy, radiotherapy, and surgery are so routine in cancer treatment. Remarkably, there are several personal features which affect the effectiveness of such treatments including nutrition, microbiome diversity, and physical activity which has distinct significant roles...

Cite
Joukar F, Mavaddati S, Mansour-Ghanaei F, et al. Gut Microbiota as a Positive Potential Therapeutic Factor in Carcinogenesis: an Overview of Microbiota-Targeted Therapy. J Gastrointest Cancer. 2020;51(2):363-378doi: 10.1007/s12029-019-00237-6.
Joukar, F., Mavaddati, S., Mansour-Ghanaei, F., & Samadani, A. A. (2020). Gut Microbiota as a Positive Potential Therapeutic Factor in Carcinogenesis: an Overview of Microbiota-Targeted Therapy. Journal of gastrointestinal cancer, 51(2), 363-378. https://doi.org/10.1007/s12029-019-00237-6
Joukar, Farahnaz, et al. "Gut Microbiota as a Positive Potential Therapeutic Factor in Carcinogenesis: an Overview of Microbiota-Targeted Therapy." Journal of gastrointestinal cancer vol. 51,2 (2020): 363-378. doi: https://doi.org/10.1007/s12029-019-00237-6
Joukar F, Mavaddati S, Mansour-Ghanaei F, Samadani AA. Gut Microbiota as a Positive Potential Therapeutic Factor in Carcinogenesis: an Overview of Microbiota-Targeted Therapy. J Gastrointest Cancer. 2020 Jun;51(2):363-378. doi: 10.1007/s12029-019-00237-6. PMID: 31025167.
Copy Download .nbib Format: NLM
Transcriptome analysis reveals key signature genes involved in the oncogenesis of lung cancer.

Cancer biomarkers : section A of Disease markers

Meng F, Zhang L, Ren Y, Ma Q.
PMID: 32831194
Cancer Biomark. 2020;29(4):475-482. doi: 10.3233/CBM-200110.

Previous studies have suggested potential signature genes for lung cancer, however, due to factors such as sequencing platform, control, data selection and filtration conditions, the results of lung cancer-related gene expression analysis are quite different. Here, we performed a...

Cite
Meng F, Zhang L, Ren Y, et al. Transcriptome analysis reveals key signature genes involved in the oncogenesis of lung cancer. Cancer Biomark. 2020;29(4):475-482doi: 10.3233/CBM-200110.
Meng, F., Zhang, L., Ren, Y., & Ma, Q. (2020). Transcriptome analysis reveals key signature genes involved in the oncogenesis of lung cancer. Cancer biomarkers : section A of Disease markers, 29(4), 475-482. https://doi.org/10.3233/CBM-200110
Meng, Fanlu, et al. "Transcriptome analysis reveals key signature genes involved in the oncogenesis of lung cancer." Cancer biomarkers : section A of Disease markers vol. 29,4 (2020): 475-482. doi: https://doi.org/10.3233/CBM-200110
Meng F, Zhang L, Ren Y, Ma Q. Transcriptome analysis reveals key signature genes involved in the oncogenesis of lung cancer. Cancer Biomark. 2020;29(4):475-482. doi: 10.3233/CBM-200110. PMID: 32831194.
Copy Download .nbib Format: NLM
Cell states can give tumorigenesis a head start.

Nature reviews. Cancer

Seton-Rogers S.
PMID: 34522022
Nat Rev Cancer. 2021 Nov;21(11):685. doi: 10.1038/s41568-021-00410-9.

No abstract available.

Cite
Seton-Rogers S. Cell states can give tumorigenesis a head start. Nat Rev Cancer. 2021;21(11):685doi: 10.1038/s41568-021-00410-9.
Seton-Rogers, S. (2021). Cell states can give tumorigenesis a head start. Nature reviews. Cancer, 21(11), 685. https://doi.org/10.1038/s41568-021-00410-9
Seton-Rogers, Sarah. "Cell states can give tumorigenesis a head start." Nature reviews. Cancer vol. 21,11 (2021): 685. doi: https://doi.org/10.1038/s41568-021-00410-9
Seton-Rogers S. Cell states can give tumorigenesis a head start. Nat Rev Cancer. 2021 Nov;21(11):685. doi: 10.1038/s41568-021-00410-9. PMID: 34522022.
Copy Download .nbib Format: NLM
The complex interplay of gut microbiota with the five most common cancer types: From carcinogenesis to therapeutics to prognoses.

Critical reviews in oncology/hematology

Jaye K, Li CG, Bhuyan DJ.
PMID: 34293459
Crit Rev Oncol Hematol. 2021 Sep;165:103429. doi: 10.1016/j.critrevonc.2021.103429. Epub 2021 Jul 19.

The association between human gut microbiota and cancers has been an evolving field of biomedical research in recent years. The gut microbiota is composed of the microorganisms residing in the gastrointestinal system that interact with the host to regulate...

Cite
Jaye K, Li CG, Bhuyan DJ. The complex interplay of gut microbiota with the five most common cancer types: From carcinogenesis to therapeutics to prognoses. Crit Rev Oncol Hematol. 2021;165:103429doi: 10.1016/j.critrevonc.2021.103429.
Jaye, K., Li, C. G., & Bhuyan, D. J. (2021). The complex interplay of gut microbiota with the five most common cancer types: From carcinogenesis to therapeutics to prognoses. Critical reviews in oncology/hematology, 165103429. https://doi.org/10.1016/j.critrevonc.2021.103429
Jaye, Kayla, et al. "The complex interplay of gut microbiota with the five most common cancer types: From carcinogenesis to therapeutics to prognoses." Critical reviews in oncology/hematology vol. 165 (2021): 103429. doi: https://doi.org/10.1016/j.critrevonc.2021.103429
Jaye K, Li CG, Bhuyan DJ. The complex interplay of gut microbiota with the five most common cancer types: From carcinogenesis to therapeutics to prognoses. Crit Rev Oncol Hematol. 2021 Sep;165:103429. doi: 10.1016/j.critrevonc.2021.103429. Epub 2021 Jul 19. PMID: 34293459.
Copy Download .nbib Format: NLM
Characteristic patterns of cancer incidence: Epidemiological data, biological theories, and multistage models.

Progress in biophysics and molecular biology

Hiller J, Vallejo C, Betthauser L, Keesling J.
PMID: 27836510
Prog Biophys Mol Biol. 2017 Mar;124:41-48. doi: 10.1016/j.pbiomolbio.2016.11.002. Epub 2016 Nov 10.

We investigate and classify several patterns in cancer incidence and relative risk data which persist across different countries and multiple published studies. We then explore biological hypotheses as well as many mathematical models in the literature that attempt to...

Cite
Hiller J, Vallejo C, Betthauser L, et al. Characteristic patterns of cancer incidence: Epidemiological data, biological theories, and multistage models. Prog Biophys Mol Biol. 2016;124:41-48doi: 10.1016/j.pbiomolbio.2016.11.002.
Hiller, J., Vallejo, C., Betthauser, L., & Keesling, J. (2017). Characteristic patterns of cancer incidence: Epidemiological data, biological theories, and multistage models. Progress in biophysics and molecular biology, 12441-48. https://doi.org/10.1016/j.pbiomolbio.2016.11.002
Hiller, Josh, et al. "Characteristic patterns of cancer incidence: Epidemiological data, biological theories, and multistage models." Progress in biophysics and molecular biology vol. 124 (2017): 41-48. doi: https://doi.org/10.1016/j.pbiomolbio.2016.11.002
Hiller J, Vallejo C, Betthauser L, Keesling J. Characteristic patterns of cancer incidence: Epidemiological data, biological theories, and multistage models. Prog Biophys Mol Biol. 2017 Mar;124:41-48. doi: 10.1016/j.pbiomolbio.2016.11.002. Epub 2016 Nov 10. PMID: 27836510.
Copy Download .nbib Format: NLM
[On the problem of carcinogenesis].

Munchener medizinische Wochenschrift (1950)

BALO J.
PMID: 13864483
Munch Med Wochenschr. 1962 Aug 03;104:1424-31.

No abstract available.

Cite
BALO J. [On the problem of carcinogenesis]. Munch Med Wochenschr. 1962;104:1424-31
BALO, J. (1962). [On the problem of carcinogenesis]. Munchener medizinische Wochenschrift (1950), 1041424-31.
BALO, J. "[On the problem of carcinogenesis]." Munchener medizinische Wochenschrift (1950) vol. 104 (1962): 1424-31.
BALO J. [On the problem of carcinogenesis]. Munch Med Wochenschr. 1962 Aug 03;104:1424-31. German. PMID: 13864483.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 111 entries